Plain-English translation of NCT06588868 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study reviews the medical records of patients who have been diagnosed with cutaneous T-cell lymphoma (a rare type of skin cancer affecting certain white blood cells) and received systemic therapy — medicines that work throughout the whole body. Researchers want to understand which treatment approaches work best and help patients live longer, healthier lives in the real world, outside of controlled clinical trials.
Currently, doctors have several medicine options for treating this condition, but there is not enough clear evidence from large clinical trials to say which treatment is best for which patient or in what order to use them. This study aims to fill that gap by learning from what actually happened to real patients.
You likely qualify if…
You likely don't qualify if…
This is a retrospective study, meaning researchers will review your past medical records rather than following you forward in time. You will need to sign consent allowing the research team to access and analyze your medical information from 2016 to 2023, including details about your diagnosis, treatments you received, and how you responded to those treatments. No new visits, blood draws, or active treatment is involved — the study team simply gathers information that already exists in your medical files.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Italy